Literature DB >> 16234992

Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature.

Dan Carter1, David Olchovsky, Hagit Yonath, Pnina Langevitz, David Ezra.   

Abstract

Transverse myelitis is a rare manifestation of antiphospholipid syndrome, usually secondary to systemic lupus erythematosus (Rheum Dis Clin North Am 20:129-158, 1994). Only about 110 reports of this complication have been reported (Lupus 10:851-856, 2001). A connection has been demonstrated between positive serology for antiphospholipid and transverse myelitis (Lupus 8:109-115, 1999). Herein, we report of a young patient admitted with deep vein thrombosis and neurological manifestations of transverse myelitis with negative serology for systemic lupus erythematosus and antiphospholipid, who developed positive anticardiolipin antibody during pulse therapy with cyclophosphamide and methylprednisolone.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234992     DOI: 10.1007/s10067-005-0051-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

Review 1.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

2.  Disseminated lupus erythematosus with involvement of the spinal cord.

Authors:  P G PIPER
Journal:  J Am Med Assoc       Date:  1953-09-19

3.  Idiopathic acute transverse myelitis: MR imaging findings.

Authors:  L M Tartaglino; S E Croul; A E Flanders; J D Sweeney; R J Schwartzman; M Liem; A Amer
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

4.  Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide.

Authors:  L Barile; C Lavalle
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

5.  Optic neuritis and myelopathy in systemic lupus erythematosus.

Authors:  S Oppenheimer; B I Hoffbrand
Journal:  Can J Neurol Sci       Date:  1986-05       Impact factor: 2.104

6.  Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?

Authors:  J W IJdo; A M Conti-Kelly; P Greco; M Abedi; M Amos; J M Provenzale; T P Greco
Journal:  Lupus       Date:  1999       Impact factor: 2.911

Review 7.  Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.

Authors:  D T Boumpas; N J Patronas; M C Dalakas; C A Hakim; J H Klippel; J E Balow
Journal:  J Rheumatol       Date:  1990-01       Impact factor: 4.666

Review 8.  Transverse myelopathy in SLE: clinical features and functional outcomes.

Authors:  K F Chan; M L Boey
Journal:  Lupus       Date:  1996-08       Impact factor: 2.911

Review 9.  Proposed diagnostic criteria and nosology of acute transverse myelitis.

Authors: 
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

10.  Lupus-related myelitis: serial MR findings.

Authors:  J M Provenzale; D P Barboriak; E H Gaensler; R L Robertson; B Mercer
Journal:  AJNR Am J Neuroradiol       Date:  1994-11       Impact factor: 3.825

View more
  2 in total

Review 1.  Lupoid sclerosis.

Authors:  Briele Keiserman; Luiz Fernando Garcias da Silva; Mauro W Keiserman; Carlos Alberto von Mühlen; Henrique Luiz Staub
Journal:  Rheumatol Int       Date:  2009-10-14       Impact factor: 2.631

Review 2.  Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.

Authors:  Cécile M Yelnik; Elizabeth Kozora; Simone Appenzeller
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.